MedPath
NMPA Approval

Dapoxetine Hydrochloride Tablets

国药准字H20243544

April 17, 2024

Drug Information

盐酸达泊西汀片

片剂

30mg(按C₂₁H₂₃NO计)

化学药品

April 17, 2024

Company Information

Applicant Company

通化市万通路66号

Manufacturing Company

通化市万通路66号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸达泊西汀片 - NMPA 批准文号 | MedPath